DSIP (10MG)

Description

DSIP (Delta Sleep-Inducing Peptide) is a synthetic 9-amino acid neuropeptide originally isolated from rabbit cerebral venous blood during induced delta sleep. It is supplied as a lyophilized powder for in vitro research applications involving neuropeptide signalling, sleep-regulatory pathway biology, and opioid receptor pharmacology.

Molecular Profile
CAS Number: 62568-57-4
Molecular Weight: 848.84 Da
Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (9 amino acids)
Format: Lyophilized white powder
Storage: -20°C, desiccated
Reconstitution: Sterile bacteriostatic water

Research Context
DSIP was first characterized in the 1970s by Monnier et al. and has since been the subject of extensive preclinical research. Documented in vitro applications include opioid receptor binding studies, neuropeptide interaction assays, hypothalamic signalling pathway research, and stress-response modelling. Research teams investigating neuroendocrine peptide signalling and sleep-regulatory neuropeptide pharmacology use DSIP as a reference compound for delta wave–associated pathway studies.

This compound is available exclusively for in vitro laboratory research and scientific study conducted within Canada. It is not a drug, natural health product, or food product as defined under the Food and Drugs Act (R.S.C., 1985, c. F-27). It is not approved for human consumption, veterinary use, or any diagnostic or therapeutic application. This product has not been evaluated by Health Canada. Researchers are responsible for compliance with all applicable federal, provincial, and local regulations.